
Validea's guru fundamental report rates LAM RESEARCH CORPORATION (LRCX), a large-cap semiconductor growth stock, at 86% using its Warren Buffett-inspired 'Patient Investor' model. This high rating reflects LRCX's strong alignment with criteria for predictable profitability, low debt, and reasonable valuation, with key metrics like earnings predictability and free cash flow passing, despite a 'Fail' on Return on Total Capital. The 86% score suggests significant interest for long-term, value-oriented investors in the semiconductor space.
Lam Research Corporation (LRCX) scores a high 86% on Validea's Patient Investor model, which is based on Warren Buffett's investment principles for long-term, predictable companies. This rating indicates significant interest, as it surpasses the 80% threshold. The analysis highlights LRCX's robust fundamentals, with the company passing on key criteria including earnings predictability, low debt service, high return on equity, strong free cash flow, effective use of retained earnings, and a shareholder-friendly share repurchase program. These factors align with the model's search for durable, profitable enterprises trading at reasonable valuations. The single point of weakness identified is a 'FAIL' on the Return on Total Capital metric, which, while notable, does not detract from the overwhelmingly positive assessment based on the other eight criteria passed.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment